IP Library Granted Patent US 11,103,721
Granted Patent B2
US 11,103,721 · App. 16/032,024 · Granted Aug 31, 2021

Controller and flexible coils for administering therapy, such as for cancer therapy

Inventors: John T. Butters (Langley, WA); Bennett M. Butters (Lacey, WA); Mike Ammerman (San Clemente, CA); Scott Conway (Yorba Linda, CA); Robert Fish (Rancho Cucamonga, CA); Larry Hood (Irvine, CA); Jared Nathanson (Mission Viejo, CA); Kevin Oberkramer (Placentia, CA); Kathryn Kukulka (Laguna Beach, CA); Andrew March (Lake Forest, CA)
Assignee: Natives, Inc.
A61N2/02A61N2/002A61N2/004G01N37/005A61B2562/0223A61M2037/0007A61M2250/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,103,721
App. No.
16/032,024
Granted
Aug 31, 2021
Kind
B2
Abstract

Disclosed herein are systems and methods for providing a portable magnetic field therapy system for treatment of diseases and adverse health conditions, such as cancer.

Claims (74)

1. An apparatus for generating a therapeutic electromagnetic field signal to provide treatment for one or more ailments, the apparatus comprising:

an electromagnetic transducer having a terminal and a signal output portion coupled to a connector; and,

a signal generator comprising—

at least one processor coupled to the terminal;

a computer-readable medium, excluding transitory signals, coupled to the at least one processor and storing a therapeutic signal obtained from a sample of a chemical or biologic molecule including proteins, RNA and DNA sequences and storing processor-executable instructions that, when executed by the at least one processor, cause the at least one processor to:

produce, through the electromagnetic transducer, the therapeutic electromagnetic field signal in response to the stored therapeutic signal to provide treatment for the one or more ailments, and

start a timer and, when the timer reaches a predetermined value, disable the signal generator of the apparatus to prohibit reuse of the stored therapeutic signal,

wherein the therapeutic electromagnetic field signal is produced at a location proximate to the signal output portion of the electromagnetic transducer and has a frequency in a frequency range between 1 Hz to 22 kHz; and

wherein disabling the signal generator includes erasing the stored therapeutic signal;

a battery coupled at least to the at least one processor; and

a housing for carrying the computer-readable medium, the at least one processor, and the battery

wherein the processor is programmed to provide the stored therapeutic signal for delivery to the electromagnetic transducer.

2. The apparatus of claim 1 , wherein the therapeutic electromagnetic field signal is produced from a frequency-domain spectrum produced from a time-domain or time-series signal with transient properties that change over time.

3. The apparatus of claim 1 , wherein the instructions further cause the at least one processor to unsecure or decrypt the stored therapeutic signal.

4. The apparatus of claim 3 , wherein the stored therapeutic signal is encrypted within the signal generator, and wherein unsecuring the stored therapeutic signal includes decrypting the stored therapeutic signal.

5. The apparatus of claim 1 , wherein the instructions further cause the at least one processor to check for an appropriate connection between the electromagnetic transducer and the signal generator portion.

6. The apparatus of claim 5 , wherein checking for the appropriate connection includes determining a type of the electromagnetic transducer.

7. The apparatus of claim 6 , wherein the instructions further cause the at least one processor to adjust an amplification of the therapeutic electromagnetic field signal based on the determined type.

8. The apparatus of claim 5 , wherein checking for the appropriate connection includes reading identification information from the electromagnetic transducer.

9. The apparatus of claim 5 , wherein checking for the appropriate connection includes periodically confirming that the electromagnetic transducer continues to maintain a physical resistance value within tolerance.

10. The apparatus of claim 1 , wherein the therapeutic signal is obtained from the sample by:

providing the sample of the chemical or biologic molecule including proteins, RNA and DNA sequences within an electromagnetic shielding structure and proximate to at least one superconducting quantum interference device (SQUID) or magnetometer;

placing the sample in a container having both magnetic and electromagnetic shielding,

wherein the sample acts as a signal source for the therapeutic signal;

injecting noise into the sample in the absence of another signal from another signal source at a noise amplitude sufficient to generate stochastic resonance,

wherein the noise has a substantially uniform amplitude over multiple frequencies;

detecting, via the SQUID or magnetometer, output radiation from the sample and recording an electromagnetic time-domain signal composed of sample source radiation superimposed on the injected noise in the absence of the another signal; and

repeating the injecting and detecting at each of multiple noise levels within a selected noise-level range until source radiation from the sample is distinguishable over the injected noise.

11. A system for generating therapeutic electromagnetic field signals to provide treatment for one or more ailments, the system comprising:

one or more processors each coupled to one or more batteries;

a plug;

a therapeutic device having

a connector,

a housing,

a port to receive the plug, and

an electromagnetic transducer portion including

a terminal, and

a signal output portion coupled to the connector; and

one or more memories, coupled to the one or more processors and storing a therapeutic signal and storing instructions that, when executed by the one or more processors,

cause the system to:

direct the electromagnetic transducer portion to produce a therapeutic electromagnetic field signal in response to the therapeutic signal, and

cause the one or more processors to:

adjust an amplification of the therapeutic electromagnetic field signal based on a determined type of the therapeutic device,

wherein the stored therapeutic signal is obtained from a sample of a chemical or biologic molecule including proteins, RNA and DNA sequences to provide treatment for ailments at a location proximate to the signal output portion,

wherein the therapeutic electromagnetic field signal has a frequency in a frequency range between 1 Hz to 22 kHz, and

wherein the therapeutic electromagnetic field signal is produced from a frequency-domain spectrum produced from a time-domain or time-series signal that changes over time.

12. The system of claim 11 , wherein the therapeutic electromagnetic field signal is secured or encrypted, and wherein the instructions further cause the one or more processors to unsecure or decrypt the therapeutic electromagnetic field signal.

13. The system of claim 11 , wherein the therapeutic signal is obtained from the sample by:

providing the sample of the chemical or biologic molecule including proteins, RNA and DNA sequences within an electromagnetic shielding structure and proximate to at least one superconducting quantum interference device (SQUID) or magnetometer;

placing the sample in a container having both magnetic and electromagnetic shielding,

wherein the sample acts as a signal source for the therapeutic signal;

injecting noise into the sample in the absence of another signal from another signal source at a noise amplitude sufficient to generate stochastic resonance,

wherein the noise has a substantially uniform amplitude over multiple frequencies;

detecting, via the SQUID or magnetometer, output radiation from the sample and recording an electromagnetic time-domain signal composed of sample source radiation superimposed on the injected noise in the absence of the another signal; and

repeating the injecting and detecting at each of multiple noise levels within a selected noise-level range until source radiation from the sample is distinguishable over the injected noise.

14. An apparatus for generating therapeutic electromagnetic field signals from at least one stored therapeutic signal that treat one or more ailments in a subject, the apparatus comprising:

an electromagnetic transducer having a terminal and a signal output portion coupled to a connector; and,

a signal generator comprising—

a computer-readable medium, excluding transitory signals, for storing the at least one therapeutic signal and carrying instructions that, when executed by at least one processor coupled to the computer-readable medium and the terminal, cause the at least one processor to:

direct the electromagnetic transducer to produce a therapeutic electromagnetic field signal based upon the at least one stored therapeutic signal obtained from a sample of a chemical or biologic molecule including proteins, RNA and DNA sequences at a location of the subject proximate to the signal output portion, and

adjust an amplification of the therapeutic electromagnetic field signal based on a determined type of the therapeutic device,

wherein the therapeutic electromagnetic field signal has a frequency in a frequency range between 1 Hz to 22 kHz;

a battery coupled at least to the at least one processor; and

a housing for carrying the computer-readable medium, the at least one processor, and the battery.

15. The system of claim 14 , wherein the therapeutic electromagnetic field signal is secured or encrypted, and wherein the instructions further cause the processor to unsecure or decrypt the therapeutic electromagnetic field signal.

16. The apparatus of claim 14 , wherein the therapeutic electromagnetic field signal is produced from a frequency-domain spectrum produced from a time-domain or time-series signal that changes over time.

17. The system of claim 14 , wherein the at least one therapeutic signal is obtained from the sample by:

providing the sample of the chemical or biologic molecule including proteins, RNA and DNA sequences within an electromagnetic shielding structure and proximate to at least one superconducting quantum interference device (SQUID) or magnetometer;

placing the sample in a container having both magnetic and electromagnetic shielding,

wherein the sample acts as a signal source for the at least one therapeutic signal;

injecting noise into the sample in the absence of another signal from another signal source at a noise amplitude sufficient to generate stochastic resonance,

wherein the noise has a substantially uniform amplitude over multiple frequencies;

detecting, via the SQUID or magnetometer, output radiation from the sample and recording an electromagnetic time-domain signal composed of sample source radiation superimposed on the injected noise in the absence of the another signal; and

repeating the injecting and detecting at each of multiple noise levels within a selected noise-level range until source radiation from the sample is distinguishable over the injected noise.

Assignments (3)
SECURITY INTEREST Recorded Sep 16, 2025
From: EMULATE THERAPEUTICS, INC.
To: STREETERVILLE CAPITAL, LLC
Reel/Frame 072271/0459 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2023
From: BUTTERS, JOHN T.; BUTTERS, BENNETT M.; AMMERMAN, MIKE; CONWAY, SCOTT; FISH, ROBERT; HOOD, LARRY; NATHANSON, JARED; OBERKRAMER, KEVIN; KUKULKA, KATHRYN; MARCH, ANDREW
To: NATIVIS, INC.
Reel/Frame 064106/0086 →
ARTICLES OF AMENDMENT Recorded Jun 28, 2023
From: NATIVIS, INC.
To: EMULATE THERAPEUTICS, INC.
Reel/Frame 064161/0572 →
Continuity (3)
Division 14774688
Provisional Application 61792547 · Mar 15, 2013
Related Publication 20190184188A1 · Jun 20, 2019
Cited By (1)
US 12,269,484